about 1 per 300 000 people suffer from multiple endocrine neoplasia type 1 in the US, Genetics Home Reference website
| Country/Region | Extrapolated Prevalence | Population Estimated Used |
| Multiple endocrine neoplasia type 2 in North America (Extrapolated Statistics) |
| USA | 978,851 | 293,655,4051 |
| Canada | 108,359 WARNING! (Details) | 32,507,8742 |
| Mexico | 349,865 WARNING! (Details) | 104,959,5942 |
| Multiple endocrine neoplasia type 2 in Central America (Extrapolated Statistics) |
| Belize | 909 WARNING! (Details) | 272,9452 |
| Guatemala | 47,601 WARNING! (Details) | 14,280,5962 |
| Nicaragua | 17,865 WARNING! (Details) | 5,359,7592 |
| Multiple endocrine neoplasia type 2 in Caribbean (Extrapolated Statistics) |
| Puerto Rico | 12,993 WARNING! (Details) | 3,897,9602 |
| Multiple endocrine neoplasia type 2 in South America (Extrapolated Statistics) |
| Brazil | 613,670 WARNING! (Details) | 184,101,1092 |
| Chile | 52,746 WARNING! (Details) | 15,823,9572 |
| Colombia | 141,035 WARNING! (Details) | 42,310,7752 |
| Paraguay | 20,637 WARNING! (Details) | 6,191,3682 |
| Peru | 91,814 WARNING! (Details) | 27,544,3052 |
| Venezuela | 83,391 WARNING! (Details) | 25,017,3872 |
| Multiple endocrine neoplasia type 2 in Northern Europe (Extrapolated Statistics) |
| Denmark | 18,044 WARNING! (Details) | 5,413,3922 |
| Finland | 17,381 WARNING! (Details) | 5,214,5122 |
| Iceland | 979 WARNING! (Details) | 293,9662 |
| Sweden | 29,954 WARNING! (Details) | 8,986,4002 |
| Multiple endocrine neoplasia type 2 in Western Europe (Extrapolated Statistics) |
| Britain (United Kingdom) | 200,902 WARNING! (Details) | 60,270,708 for UK2 |
| Belgium | 34,494 WARNING! (Details) | 10,348,2762 |
| France | 201,414 WARNING! (Details) | 60,424,2132 |
| Ireland | 13,231 WARNING! (Details) | 3,969,5582 |
| Luxembourg | 1,542 WARNING! (Details) | 462,6902 |
| Monaco | 107 WARNING! (Details) | 32,2702 |
| Netherlands (Holland) | 54,393 WARNING! (Details) | 16,318,1992 |
| United Kingdom | 200,902 WARNING! (Details) | 60,270,7082 |
| Wales | 9,726 WARNING! (Details) | 2,918,0002 |
| Multiple endocrine neoplasia type 2 in Central Europe (Extrapolated Statistics) |
| Austria | 27,249 WARNING! (Details) | 8,174,7622 |
| Czech Republic | 4,153 WARNING! (Details) | 1,0246,1782 |
| Germany | 274,748 WARNING! (Details) | 82,424,6092 |
| Hungary | 33,441 WARNING! (Details) | 10,032,3752 |
| Liechtenstein | 111 WARNING! (Details) | 33,4362 |
| Poland | 128,754 WARNING! (Details) | 38,626,3492 |
| Slovakia | 18,078 WARNING! (Details) | 5,423,5672 |
| Slovenia | 6,704 WARNING! (Details) | 2,011,473 2 |
| Switzerland | 24,836 WARNING! (Details) | 7,450,8672 |
| Multiple endocrine neoplasia type 2 in Eastern Europe (Extrapolated Statistics) |
| Belarus | 34,368 WARNING! (Details) | 10,310,5202 |
| Estonia | 4,472 WARNING! (Details) | 1,341,6642 |
| Latvia | 7,687 WARNING! (Details) | 2,306,3062 |
| Lithuania | 12,026 WARNING! (Details) | 3,607,8992 |
| Russia | 479,913 WARNING! (Details) | 143,974,0592 |
| Ukraine | 159,106 WARNING! (Details) | 47,732,0792 |
| Multiple endocrine neoplasia type 2 in the Southwestern Europe (Extrapolated Statistics) |
| Azerbaijan | 26,227 WARNING! (Details) | 7,868,3852 |
| Georgia | 15,646 WARNING! (Details) | 4,693,8922 |
| Portugal | 35,080 WARNING! (Details) | 10,524,1452 |
| Spain | 134,269 WARNING! (Details) | 40,280,7802 |
| Multiple endocrine neoplasia type 2 in Southern Europe (Extrapolated Statistics) |
| Greece | 35,491 WARNING! (Details) | 10,647,5292 |
| Italy | 193,524 WARNING! (Details) | 58,057,4772 |
| Multiple endocrine neoplasia type 2 in the Southeastern Europe (Extrapolated Statistics) |
| Albania | 11,816 WARNING! (Details) | 3,544,8082 |
| Bosnia and Herzegovina | 1,358 WARNING! (Details) | 407,6082 |
| Bulgaria | 25,059 WARNING! (Details) | 7,517,9732 |
| Croatia | 14,989 WARNING! (Details) | 4,496,8692 |
| Macedonia | 6,800 WARNING! (Details) | 2,040,0852 |
| Romania | 74,518 WARNING! (Details) | 22,355,5512 |
| Serbia and Montenegro | 36,086 WARNING! (Details) | 10,825,9002 |
| Multiple endocrine neoplasia type 2 in Northern Asia (Extrapolated Statistics) |
| Mongolia | 9,171 WARNING! (Details) | 2,751,3142 |
| Multiple endocrine neoplasia type 2 in Central Asia (Extrapolated Statistics) |
| Kazakhstan | 50,479 WARNING! (Details) | 15,143,7042 |
| Tajikistan | 23,371 WARNING! (Details) | 7,011,556 2 |
| Uzbekistan | 88,034 WARNING! (Details) | 26,410,4162 |
| Multiple endocrine neoplasia type 2 in Eastern Asia (Extrapolated Statistics) |
| China | 4,329,492 WARNING! (Details) | 1,298,847,6242 |
| Hong Kong s.a.r. | 22,850 WARNING! (Details) | 6,855,1252 |
| Japan | 424,443 WARNING! (Details) | 127,333,0022 |
| Macau s.a.r. | 1,484 WARNING! (Details) | 445,2862 |
| North Korea | 75,658 WARNING! (Details) | 22,697,5532 |
| South Korea | 160,779 WARNING! (Details) | 48,233,7602 |
| Taiwan | 75,832 WARNING! (Details) | 22,749,8382 |
| Multiple endocrine neoplasia type 2 in Southwestern Asia (Extrapolated Statistics) |
| Turkey | 229,646 WARNING! (Details) | 68,893,9182 |
| Multiple endocrine neoplasia type 2 in Southern Asia (Extrapolated Statistics) |
| Afghanistan | 95,045 WARNING! (Details) | 28,513,6772 |
| Bangladesh | 471,134 WARNING! (Details) | 141,340,4762 |
| Bhutan | 7,285 WARNING! (Details) | 2,185,5692 |
| India | 3,550,235 WARNING! (Details) | 1,065,070,6072 |
| Pakistan | 530,654 WARNING! (Details) | 159,196,3362 |
| Sri Lanka | 66,350 WARNING! (Details) | 19,905,1652 |
| Multiple endocrine neoplasia type 2 in Southeastern Asia (Extrapolated Statistics) |
| East Timor | 3,397 WARNING! (Details) | 1,019,2522 |
| Indonesia | 794,843 WARNING! (Details) | 238,452,9522 |
| Laos | 20,227 WARNING! (Details) | 6,068,1172 |
| Malaysia | 78,408 WARNING! (Details) | 23,522,4822 |
| Philippines | 287,472 WARNING! (Details) | 86,241,6972 |
| Singapore | 14,512 WARNING! (Details) | 4,353,8932 |
| Thailand | 216,218 WARNING! (Details) | 64,865,5232 |
| Vietnam | 275,542 WARNING! (Details) | 82,662,8002 |
| Multiple endocrine neoplasia type 2 in the Middle East (Extrapolated Statistics) |
| Gaza strip | 4,416 WARNING! (Details) | 1,324,9912 |
| Iran | 225,010 WARNING! (Details) | 67,503,2052 |
| Iraq | 84,582 WARNING! (Details) | 25,374,6912 |
| Israel | 20,663 WARNING! (Details) | 6,199,0082 |
| Jordan | 18,704 WARNING! (Details) | 5,611,2022 |
| Kuwait | 7,525 WARNING! (Details) | 2,257,5492 |
| Lebanon | 12,590 WARNING! (Details) | 3,777,2182 |
| Saudi Arabia | 85,986 WARNING! (Details) | 25,795,9382 |
| Syria | 60,056 WARNING! (Details) | 18,016,8742 |
| United Arab Emirates | 8,413 WARNING! (Details) | 2,523,9152 |
| West Bank | 7,704 WARNING! (Details) | 2,311,2042 |
| Yemen | 66,749 WARNING! (Details) | 20,024,8672 |
| Multiple endocrine neoplasia type 2 in Northern Africa (Extrapolated Statistics) |
| Egypt | 253,724 WARNING! (Details) | 76,117,4212 |
| Libya | 18,771 WARNING! (Details) | 5,631,5852 |
| Sudan | 130,493 WARNING! (Details) | 39,148,1622 |
| Multiple endocrine neoplasia type 2 in Western Africa (Extrapolated Statistics) |
| Congo Brazzaville | 9,993 WARNING! (Details) | 2,998,0402 |
| Ghana | 69,190 WARNING! (Details) | 20,757,0322 |
| Liberia | 11,302 WARNING! (Details) | 3,390,6352 |
| Niger | 37,868 WARNING! (Details) | 11,360,5382 |
| Nigeria | 59,167 WARNING! (Details) | 12,5750,3562 |
| Senegal | 36,173 WARNING! (Details) | 10,852,1472 |
| Sierra leone | 19,612 WARNING! (Details) | 5,883,8892 |
| Multiple endocrine neoplasia type 2 in Central Africa (Extrapolated Statistics) |
| Central African Republic | 12,474 WARNING! (Details) | 3,742,4822 |
| Chad | 31,795 WARNING! (Details) | 9,538,5442 |
| Congo kinshasa | 194,390 WARNING! (Details) | 58,317,0302 |
| Rwanda | 27,462 WARNING! (Details) | 8,238,6732 |
| Multiple endocrine neoplasia type 2 in Eastern Africa (Extrapolated Statistics) |
| Ethiopia | 237,788 WARNING! (Details) | 71,336,5712 |
| Kenya | 109,940 WARNING! (Details) | 32,982,1092 |
| Somalia | 27,682 WARNING! (Details) | 8,304,6012 |
| Tanzania | 120,236 WARNING! (Details) | 36,070,7992 |
| Uganda | 87,967 WARNING! (Details) | 26,390,2582 |
| Multiple endocrine neoplasia type 2 in Southern Africa (Extrapolated Statistics) |
| Angola | 36,595 WARNING! (Details) | 10,978,5522 |
| Botswana | 5,464 WARNING! (Details) | 1,639,2312 |
| South Africa | 148,161 WARNING! (Details) | 44,448,4702 |
| Swaziland | 3,897 WARNING! (Details) | 1,169,2412 |
| Zambia | 36,752 WARNING! (Details) | 11,025,6902 |
| Zimbabwe | 12,239 WARNING! (Details) | 1,2671,8602 |
| Multiple endocrine neoplasia type 2 in Oceania (Extrapolated Statistics) |
| Australia | 66,377 WARNING! (Details) | 19,913,1442 |
| New Zealand | 13,312 WARNING! (Details) | 3,993,8172 |
| Papua New Guinea | 18,067 WARNING! (Details) | 5,420,2802 |
The word 'prevalence' of Multiple endocrine neoplasia type 2 usually means the estimated population
of people who are managing Multiple endocrine neoplasia type 2 at any given time (i.e. people with Multiple endocrine neoplasia type 2).
The term 'incidence' of Multiple endocrine neoplasia type 2 means the annual diagnosis rate,
or the number of new cases of Multiple endocrine neoplasia type 2 diagnosed each year (i.e. getting Multiple endocrine neoplasia type 2).
Hence, these two statistics types can differ:
a short disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.